Cargando…
Using CRISPR to enhance T cell effector function for therapeutic applications
T cells are critical to fight pathogenic microbes and combat malignantly transformed cells in the fight against cancer. To exert their effector function, T cells produce effector molecules, such as the pro-inflammatory cytokines IFN-γ, TNF-α and IL-2. Tumors possess many inhibitory mechanisms that d...
Autor principal: | Freen-van Heeren, Julian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885876/ https://www.ncbi.nlm.nih.gov/pubmed/33604565 http://dx.doi.org/10.1016/j.cytox.2020.100049 |
Ejemplares similares
-
Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV
por: Freen-van Heeren, Julian J.
Publicado: (2022) -
Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses
por: Freen-van Heeren, Julian J.
Publicado: (2021) -
Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function
por: Popović, Branka, et al.
Publicado: (2023) -
Memory CD8(+) T cells upregulate glycolysis and effector functions under limiting oxygen conditions
por: Beumer‐Chuwonpad, Ammarina, et al.
Publicado: (2022) -
Human T cells employ conserved AU‐rich elements to fine‐tune IFN‐γ production
por: Freen‐van Heeren, Julian J., et al.
Publicado: (2020)